J. Cox

发表

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

V. Rusch, R. Livingston, D. Gandara, 2009, The Lancet.

Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography.

George Starkschall, Tinsu Pan, Radhe Mohan, 2007, International journal of radiation oncology, biology, physics.

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

George Starkschall, Karl Prado, Tinsu Pan, 2007, International journal of radiation oncology, biology, physics.

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

T. Pajak, J. Cox, J. Stetz, 1995, International journal of radiation oncology, biology, physics.

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

A. Markoe, K. Russell, H. Sandler, 2000, International journal of radiation oncology, biology, physics.

4D Proton treatment planning strategy for mobile lung tumors.

Joe Y. Chang, He Wang, Lei Dong, 2007, International journal of radiation oncology, biology, physics.

Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy.

Radhe Mohan, Lei Dong, He Wang, 2004, International journal of radiation oncology, biology, physics.

Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance.

Peter A Balter, Ritsuko Komaki, Rudy Guerra, 2007, International journal of radiation oncology, biology, physics.

Lung Cancer, Third Edition

W. Hong, J. Roth, J. Cox, 2008 .

Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy.

Laurence Court, Lei Dong, Yongbin Zhang, 2013, Practical radiation oncology.

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

S. Tucker, J. Cox, F. Cabanillas, 2001, International journal of radiation oncology, biology, physics.

Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer.

T. Pajak, W. Sause, J. Cox, 1997, Lung cancer.

Weekly localization films and detection of field placement errors.

J. Cox, R. Byhardt, A. Hornburg, 1978, International journal of radiation oncology, biology, physics.

Postgraduate training in radiation oncology in the United States, 1986.

J. Cox, D. Flynn, D. D. Pittman, 1987, International journal of radiation oncology, biology, physics.

Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.

R. Komaki, J. Erasmus, J. Cox, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription.

George Starkschall, Steven J Frank, Zhongxing Liao, 2003, International journal of radiation oncology, biology, physics.

Analysis of the probability and risk of cause-specific failure.

T. Pajak, J. Cox, R. Caplan, 1994, International journal of radiation oncology, biology, physics.

Oncology at the end of the century.

J. Cox, 1999, International journal of radiation oncology, biology, physics.

Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.

Joe Y. Chang, P. Balter, M. Bucci, 2007, International journal of radiation oncology, biology, physics.

Image-guided radiation therapy for non-small cell lung cancer.

George Starkschall, Peter Balter, Radhe Mohan, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.

Radhe Mohan, Joe Y. Chang, Zhongxing Liao, 2013, Medical Dosimetry.

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.

Radhe Mohan, Edward S. Kim, Xiong Wei, 2010, International journal of radiation oncology, biology, physics.

Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy.

He Wang, Lei Dong, J. O'Daniel, 2007, International journal of radiation oncology, biology, physics.

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.

D. Grignon, W. Shipley, J. Cox, 2000, International journal of radiation oncology, biology, physics.

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

A. Markoe, J. Earle, H. Sandler, 2002, International journal of radiation oncology, biology, physics.

Report of the American Society for Therapeutic Radiology and Oncology Working Group on the scope of radiation oncology (SCOPE).

M. Dewhirst, M. Zelefsky, J. Ajani, 2002, International journal of radiation oncology, biology, physics.

Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.

R. Mohan, A. Garden, R. Weber, 2014, International journal of radiation oncology, biology, physics.

Patterns of failure in patients with inoperable carcinoma of the lung

Z. Petrovich, J. Cox, K. Stanley, 1981, Cancer.

Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non‐Small Cell Lung Cancer

Joe Y. Chang, R. Komaki, J. Cox, 2014 .

Local control and survival after external irradiation for adenocarcinoma of the prostate.

J. Cox, R. Byhardt, J. Wilson, 1981, International journal of radiation oncology, biology, physics.

Agreement rates among single photon emission computed tomography using gallium‐67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome

J. Cox, P. Allen, E. Kim, 2000, Cancer.

Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy

P. Mclaughlin, F. Cabanillas, J. Cox, 2003, Cancer.

Results of whole-brain irradiation for metastases from small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1980, Cancer treatment reports.

Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation.

J. Cox, R. Komaki, W. Whitson, 1981, Cancer treatment reports.

Comparing Proton Beam to Intensity Modulated Radiation Therapy Planning in Esophageal Cancer

Steven H. Lin, Z. Liao, J. Cox, 2015 .

Improving cardiac dosimetry: Alternative beam arrangements for intensity modulated radiation therapy planning in patients with carcinoma of the distal esophagus.

Joe Y. Chang, R. Komaki, J. Cox, 2012, Practical radiation oncology.

Esophageal cancer dose escalation using a simultaneous integrated boost technique.

J. Ajani, D. Gomez, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.

J. Ajani, S. Swisher, T. Buchholz, 2009, International journal of radiation oncology, biology, physics.

Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.

J. Ajani, J. Roth, Q. Wei, 2006, International journal of radiation oncology, biology, physics.

2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

J. Ajani, J. Roth, S. Swisher, 2004, Cancer.

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.

J. Ajani, J. Roth, S. Swisher, 2003, International journal of radiation oncology, biology, physics.

Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer

D. Gomez, R. Komaki, J. Cox, 2011 .

Evaluation of conventional radiotherapy vs. conformal radiotherapy in the treatment of non-small-cell lung cancer after surgical resection

Z. Liao, J. Cox, P. Allen, 2007 .

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.

Joe Y. Chang, T. Guerrero, J. Roth, 2004, International journal of radiation oncology, biology, physics.

The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.

M. Graham, C. Perez, B. Emami, 2003, Lung cancer.

Chemoradiation for malignant epithelial tumors.

J. Cox, 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Evolution and accomplishments of the Radiation Therapy Oncology Group.

J. Cox, James D. Cox, 1995, International journal of radiation oncology, biology, physics.

The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1984, Seminars in oncology.

Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients

B. Erickson, J. Cox, N. Janjan, 2005, Breast Cancer Research and Treatment.

Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

M. Martel, Li-E. Wang, Q. Wei, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.

Joe Y. Chang, J. Ajani, S. Swisher, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy

R. Mohan, J. Ajani, S. Swisher, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

D. Gomez, S. Swisher, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.

W. Curran, M. Graham, J. Cox, 1992, Journal of the National Cancer Institute.

Breast cancer: Is ethnicity an independent prognostic factor for survival?

J. Cox, P. Perkins, C. Cooksley, 1996, Cancer.

Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report.

R. Arriagada, M. Fukuoka, J. Cox, 1994, Lung cancer.

Radiation dosimetry and biodistribution of 99mTc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer

David J. Yang, R. Munden, K. Forster, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis

M. Graham, C. Perez, B. Emami, 1996 .

FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy

Joe Y. Chang, R. Komaki, J. Erasmus, 2012, Radiation Oncology.

Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).

L. Fuller, J. Cox, M. Meistrich, 2000, International journal of radiation oncology, biology, physics.

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.

Z. Liao, S. Tucker, L. Fuller, 1998, International journal of radiation oncology, biology, physics.

Prospective Exploratory Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy with High-Dose Heart Exposure

Joe Y. Chang, D. Gomez, J. Welsh, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.

L. Fuller, J. Cox, B. Brown, 1997, International journal of radiation oncology, biology, physics.

Radiotherapy for lung cancer.

N. Bleehen, J. Cox, J. Cox, 1985, International journal of radiation oncology, biology, physics.

Characteristics of long‐term survivors after treatment for inoperable carcinoma of the lung

Hongyung Choi, J. Cox, R. Komaki, 1985, American journal of clinical oncology.

Long-term outcomes of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017 .

Utility of four-dimensional computed tomography for analysis of intrafractional and interfractional variation in lung volumes.

R. Mohan, G. Starkschall, J. Cox, 2008, International journal of radiation oncology, biology, physics.

Primary malignant germinal tumors of the mediastinum. A study of 24 cases

J. Cox, 1975, Cancer.

Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.

W. Hong, J. Roth, T. McDonnell, 2002, International journal of radiation oncology, biology, physics.

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.

F. Khuri, C. Stevens, R. Komaki, 2002, Seminars in radiation oncology.

Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).

J. Cox, A. Hartz, R. Byhardt, 1986, International journal of radiation oncology, biology, physics.

SUV by FDG-PET predicts outcome of non-small cell lung cancer

K. Forster, J. Roth, R. Komaki, 2003 .

NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.

D. Ettinger, M. Kris, R. Ginsberg, 1996, Oncology.

Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".

S. Lippman, J. Roth, S. Swisher, 2008, Chest.

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer

Joe Y. Chang, R. Komaki, E. Sulman, 2009, Radiation oncology.

4D CT-based Treatment Planning for Intensity-Modulated Radiation Therapy and Proton Therapy for Distal Esophagus Cancer

T. Guerrero, R. Mohan, Xiaodong Zhang, 2008 .

Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410

W. Curran, S. Hauser, W. Sause, 2000 .

Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease.

J. Cox, L. Kun, J. Reavis, 1988, International journal of radiation oncology, biology, physics.

2485 : Preliminary Report of Image-Guided Hypofractionated Stereotactic Body Radiotherapy to Treat Patients With Medically Inoperable Stage I or Isolated Peripheral Lung Recurrent Non-Small Cell Lung Cancer

T. Guerrero, J. Roth, P. Balter, 2006 .

Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.

J. Roth, C. Stevens, J. Cox, 2003, International journal of radiation oncology, biology, physics.

Standards for diagnosis and management of invasive breast carcinoma

D. Winchester, J. Cox, J. Cox, 1998, CA: a cancer journal for clinicians.

lLong-Term Outcomes after Proton Therapy, with Concurrent Chemotherapy, for Stage II-III Inoperable Non-Small Cell Lung Cancer

Joe Y. Chang, Z. Liao, L. Levy, 2016 .

Adaptive / non-adaptive proton radiation planning and outcome in a phase II trial for locally advanced non-small cell lung cancer

Joe Y. Chang, R. Mohan, R. Komaki, 2012 .

2727 : Impact of Respiration-Induced Tumor Motion Uncertainties on Adaptive Treatment Delivery Strategies: A Comparison Through Repeat 4D CT Imaging

R. Mohan, P. Keall, S. Vedam, 2006 .

2463: Intra-Thoracic Patterns of Failure for Non-Small Cell Lung Cancer (NSCLC) With PET/CT-Defined Target Delineation

P. Balter, R. Komaki, J. Cox, 2006 .

4-D CT Based and Daily In-room CT-guided Stereotactic Body Radiotherapy (SBRT) for Lung Cancer

Lei Dong, P. Balter, M. McAleer, 2007 .

O-152 Analysis of acute toxicity results of intensity modulated radiationtherapy (IMRT) in the treatment of non-small cell lung cancer (NSCLC)

Joe Y. Chang, T. Guerrero, C. Stevens, 2005 .

Exclusion of Elective Nodal Irradiation Does Not Decrease Local Regional Control of Non-Small Cell Lung Cancer

T. Guerrero, C. Stevens, R. Komaki, 2005 .

Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.

J. Cox, F. Cabanillas, C. Ha, 1999, Radiology.

Irradiation for bronchial carcinoma: Reasons for failure. I. Analysis of local control as a function of dose, time, and fractionation

J. Cox, R. Komaki, D. Eisert, 1976, Cancer.

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.

Joe Y. Chang, T. Guerrero, R. Herbst, 2007, International journal of radiation oncology, biology, physics.

High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy

Joe Y. Chang, M. Spitz, Xifeng Wu, 2005, Clinical Cancer Research.

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.

David J. Yang, L. Broemeling, R. Wendt, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Patients with Squamous Cell Carcinoma of the Head and Neck

L. Broemeling, R. Wendt, D. Podoloff, 2004 .

IClinicalTrial ofThoracic Radiotherapy and Concurrent Celecoxib for Patientswith Unfavorable Performance Status Inoperable / Unresectable Non ^ Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005 .

Radiotherapeutic management of complications of carcinoma of the lung.

J. Cox, J. Cox, 1982, Clinics in chest medicine.

Combination of a COX-2 Inhibitor With Radiotherapy or Radiochemotherapy in the Treatment of Thoracic Cancer

C. Stevens, Z. Liao, J. Cox, 2003, American journal of clinical oncology.

Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.

T. McDonnell, L. Peters, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma).

J. Cox, R. H. Koehl, F. King, 1974, Radiology.

Apparently localized and regionally advanced malignant lymphoreticular tumors in the adult. Early course following irradiation

J. Cox, R. Gérard-Marchant, A. Laugier, 1972, Cancer.

The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.

J. Manning, J. Cox, F. Cabanillas, 2000, International journal of radiation oncology, biology, physics.

Clinical course of solitary extramedullary plasmacytoma.

J. Cox, D. Weber, C. Ha, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Primary parotid lymphoma: the effect of International Prognostic Index on outcome.

P. Mclaughlin, J. Cox, F. Cabanillas, 1997, Leukemia & lymphoma.

Causes of treatment failure and death in carcinoma of the lung.

J. Cox, R. Yesner, J. Cox, 1981, The Yale journal of biology and medicine.

Cervical Nodal Metastasis from an Unknown Primary Carcinoma

J. Cox, J. Haas, 1989 .

Role of radiation therapy in small cell anaplastic carcinoma of the lung.

R. Wittes, P. Bunn, N. Bleehen, 1983, Cancer treatment reports.

Proton Therapy vs. IMRT for Prostate Cancer: A Dosimetric Comparison

Lei Dong, R. Mohan, D. Kuban, 2007 .

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.

J. Cox, F. Cabanillas, A. Younes, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single and double plane implants: a comparison of the Manchester System with the Paris System.

J. Cox, M. Gillin, R. Kline, 1984, International journal of radiation oncology, biology, physics.

Fit of a Generalized Lyman Normal-Tissue Complication Probability (NTCP) Model to Grade ≥ 2 Late Rectal Toxicity Data From Patients Treated on Protocol RTOG 94-06

Lei Dong, R. Mohan, D. Kuban, 2007 .

Localized non‐Hodgkin lymphoma involving the thyroid gland

J. Cox, L. Medeiros, R. Wilder, 2001, Cancer.

Primary non-Hodgkin lymphoma of the small bowel.

L. Fuller, J. Cox, P. Allen, 1999, Radiology.

Lymphoma of the nasal cavity and paranasal sinuses

J. Cox, V. Kavadi, C. Ha, 1997, Cancer.

Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment.

W. Woodward, M. Andreeff, J. Cox, 2007, Cancer research.

Evidence in oncology. The Janeway lecture 2000.

J. Cox, 2000, Cancer journal.

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.

J. Cox, D. Weber, C. Ha, 1998, International journal of radiation oncology, biology, physics.

Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results.

J. Cox, M. Goswitz, C. Schultz, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is long‐term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?

J. Cox, C. Lawton, R. Byhardt, 1992, Cancer.

Thymoma: treatment and prognosis.

R. Komaki, J. Cox, A. Pollack, 1992, International journal of radiation oncology, biology, physics.

Integration of chemotherapy and radiation therapy for small cell carcinoma of the lung.

J. Cox, R. Byhardt, P. Holoye, 1982, International journal of radiation oncology, biology, physics.

Irradiation for inoperable carcinoma of the lung and high performance status.

J. Cox, R. Komaki, D. R. Eierst, 1980, JAMA.

The role of radiation therapy for carcinoma of the lung.

J. Cox, J. Cox, 1981, The Yale journal of biology and medicine.

Dose-time relationships and the local control of small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1978, Radiology.

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

Alfred R. Smith, J. Cox, A. Mahajan, 2005, International journal of radiation oncology, biology, physics.

Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.

S. Tucker, P. Mclaughlin, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Stage III follicular lymphoma: long-term follow-up and patterns of failure.

S. Tucker, P. Mclaughlin, J. Cox, 2003, International journal of radiation oncology, biology, physics.

Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.

M. McAleer, R. Komaki, W. Sause, 2010, International journal of radiation oncology, biology, physics.

Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)

W. Curran, R. Komaki, S. Hauser, 2000 .

Carcinoid tumors of the lung and family history of cancer.

J. Cox, P. Perkins, B. Kemp, 1997, Journal of clinical epidemiology.

O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)

V. Rusch, R. Livingston, F. Shepherd, 2005 .

Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease

Maria A. Rodriguez, L. Levy, E. Atkinson, 2004, American journal of clinical oncology.

Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience

D. Kuban, K. Hunt, J. Ajani, 2008, Oncology.

Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report.

J. Cox, A. Hartz, R. Byhardt, 1987, Archives of otolaryngology--head & neck surgery.

The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies

R. Hoffmann, J. Cox, P. Ritch, 1987, The Laryngoscope.

Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?

J. Cox, R. Kline, J. Cox, 1981, International journal of radiation oncology, biology, physics.

[Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials].

D. Grignon, W. Shipley, J. Cox, 2001 .

Localized primary non-Hodgkin lymphoma of the breast.

J. Cox, F. Cabanillas, C. Ha, 1998, American journal of clinical oncology.

Biology-based combined-modality radiotherapy: workshop report.

R. Komaki, J. Cox, L. Milas, 2001, International journal of radiation oncology, biology, physics.

Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.

G. Starkschall, C. Stevens, R. Komaki, 2003, International journal of radiation oncology, biology, physics.

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

D. Gomez, J. Welsh, Steven H. Lin, 2017, International journal of radiation oncology, biology, physics.

HighMutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage IIINon^Small Cell Lung Cancer Treatedwith Radiotherapy and Chemotherapy

Joe Y. Chang, M. Spitz, C. Stevens, 2005 .

Stage III nodular lymphoreticular tumors (non‐Hodgkin's lymphoma): Results of central lymphatic irradiation

J. Cox, J. Wilson, L. Kun, 1981, Cancer.

In response to Dr. Denham et al.

T. Pajak, J. Cox, R. Caplan, 1996 .

RESPONSE TO MACBETH AND PRICE CONCERNING OUR PAPER “Novel approaches to locally advanced non-small cell lung cancer”

C. Stevens, R. Komaki, J. Cox, 2001 .

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.

K. Forster, J. Roth, R. Herbst, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Total body irradiation vs. chemotherapy as a systemic adjuvant for small cell carcinoma of the lung.

J. Cox, R. Byhardt, J. Wilson, 1979, International journal of radiation oncology, biology, physics.

Single Nucleotide Polymorphism at rs1982073:T869C of the TGF (cid:1) 1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Deﬁnitive Radiotherapy

Q. Wei, Z. Liao, Zhensheng Liu, 2009 .

A step toward ending the controversies in Hodgkin's disease.

J. Cox, L. Kun, K. Schewe, 1989, International journal of radiation oncology, biology, physics.

A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.

Maria A. Rodriguez, S. Tucker, P. Mclaughlin, 2003, International journal of radiation oncology, biology, physics.

Long-Term F ollow-Up o f a P rospective S tudy o f C ombined Modality T herapy f or S tage I -II I ndolent N on-Hodgkin's Lymphoma

Maria A. Rodriguez, L. Fuller, P. Mclaughlin, 2003 .

Molecular Response of Follicular Lymphoma to Cyclophosphamide, Doxorubicin, Vincristine, Prednisone C(H)OP or COP‐Based Therapy as Measured by Polymerase Chain Reaction Evidence of Translocation (14;18)(q32;q21)

S. Tucker, P. Mclaughlin, F. Cabanillas, 2004, Cancer journal.

Update of toxicity following 3D radiation therapy for prostate cancer on RTOG 9406

A. Markoe, H. Sandler, J. Purdy, 2000 .

Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas.

J. Cox, R. Komaki, J. Wilson, 1988, International journal of radiation oncology, biology, physics.

Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma.

T. Buchholz, J. Cox, B. Dabaja, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.

L. Fuller, P. Mclaughlin, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Altered fractionation for non-small cell carcinoma of the lung. Rationale for the prospective trials of the Radiation Therapy Oncology Group.

K. Fu, W. Sause, C. Perez, 1989, Chest.

The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia

H. Kantarjian, J. Cox, C. Koller, 2004, Cancer.

A Multidisciplinary Approach to Therapy for Unresectable Malignant Thymoma

W. Hong, J. Roth, J. Nesbitt, 1998, Annals of Internal Medicine.

The radiation therapy oncology group experience altered fractionation in lung cancer

T. Pajak, W. Sause, B. Emami, 1993 .

Failure analysis of inoperable carcinoma of the lung of all histopathologic types and squamous cell carcinoma of the esophagus

J. Cox, 1983 .

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy

J. Manning, F. Cabanillas, J. Cox, 2001, Cancer.

Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes.

J. Cox, R. Byhardt, J. Cox, 1983, Cancer treatment reports.

Clinical versus pathologic stage I and II Hodgkin's disease.

J. Cox, T. J. Stoffel, 1980, Oncology.

Paternalism, informed consent and Tuskegee.

J. Cox, J. Cox, 1998, International journal of radiation oncology, biology, physics.

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

L. Gaspar, K. Fu, B. Emami, 1997, International journal of radiation oncology, biology, physics.

Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease

J. Cox, M. Gillin, N. Janjan, 1988, Cancer.

Is immediate chest radiotherapy obligatory for any or all patients with limited-stage non-small cell carcinoma of the lung? Yes.

J. Cox, R. Komaki, R. Byhardt, 1983, Cancer treatment reports.

Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.

Helen H Liu, J. Ajani, S. Swisher, 2006, World journal of gastroenterology.

Presidential address: Fractionation: A paradigm for clinical research in radiation oncology

J. Cox, 1987 .

Fractionation: a paradigm for clinical research in radiation oncology.

J. Cox, 1986, International journal of radiation oncology, biology, physics.

Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.

R. Mohan, M. Martel, P. Balter, 2012, International journal of radiation oncology, biology, physics.

Preliminary Report of Radiation Pneumonitis (RP) in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Intensity Modulated Radiotherapy (IMRT) and Concurrent Chemotherapy (ConChT)

R. Mohan, R. Komaki, Z. Liao, 2005 .

Central lymphatic irradiation to low dose for advanced nodular lymphoreticular tumors (non-Hodgkin's lymphoma).

J. Cox, 1978, Radiology.

Total central lymphatic irradiation for stage III nodular malignant lymphoreticular tumors.

J. Cox, J. Cox, 1976, International journal of radiation oncology, biology, physics.

Malignant lymphoid tumors of lymph nodes in the adult.

J. Cox, R. H. Koehl, F. King, 1974, Archives of pathology.

The role of consolidation irradiation in combined modality therapy of small cell carcinoma of the lung.

J. Cox, R. Byhardt, P. Holoye, 1981, International journal of radiation oncology, biology, physics.

Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small‐cell carcinoma of the lung

J. Cox, R. Komaki, R. Byhardt, 1981, Cancer.

Extended‐Field Radiation Therapy for Prostatic Carcinoma with Para‐Aortic Lymph Node Metastasis

J. Cox, A. Hartz, C. Glisch, 1986, American journal of clinical oncology.

Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level IV

A. Markoe, H. Sandler, J. Purdy, 2002 .

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol.

K. Shin, T. Pajak, B. Emami, 1993, International journal of radiation oncology, biology, physics.

Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience.

R. Komaki, W. Sause, J. Cox, 1999, International journal of radiation oncology, biology, physics.

A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors

J. Roth, D. Gomez, S. Swisher, 2012, Cancer.

Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience

Joe Y. Chang, T. Guerrero, J. Ajani, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies.

T. Pajak, W. Sause, C. Perez, 1994, Lung cancer.

Induction chemotherapy for non-small cell carcinoma of the lung: limitations and lessons.

J. Cox, 1991, International journal of radiation oncology, biology, physics.

Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin.

J. Cox, C. Schultz, J. Wilson, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Larry Emanuel Kun, March 10, 1946-May 27, 2018.

T. Merchant, H. Choy, S. Donaldson, 2019, International journal of radiation oncology, biology, physics.

Recurrence patterns by treatment modality of carcinomas of the floor of the mouth and oral tongue.

R. Lehman, J. Cox, R. Byhardt, 1982, American journal of otolaryngology.

Patterns of failure and results of preoperative irradiation vs radiation therapy alone in carcinoma of the pyriform sinus.

J. Cox, R. Byhardt, 1980, International journal of radiation oncology, biology, physics.

Particle Therapy Clinical Trials

C. Grau, J. Cox, J. Langendijk, 2018 .

Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston.

R. Mohan, J. Cox, M. Gillin, 2007, International journal of radiation oncology, biology, physics.

A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract.

R. Hoffmann, J. Cox, P. Ritch, 1986, International journal of radiation oncology, biology, physics.

Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.

D. Gomez, S. Swisher, Steven H. Lin, 2012, International journal of radiation oncology, biology, physics.

Preparing for the future of radiation oncology.

T. Buchholz, J. Cox, W. McBride, 2007, Journal of the American College of Radiology : JACR.

Phase III trial of hormonal cytoreduction in conjunction with definitive radiotherapy in locally advanced prostate carcinoma: the emerging role of psa in the assessment of outcome

R. Abrams, P. Rubin, W. Sause, 1993 .

High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.

L. Fuller, F. Cabanillas, J. Cox, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Hematologic recovery after central lymphatic irradiation for patients with stage I–III follicular lymphoma

S. Tucker, P. Mclaughlin, F. Cabanillas, 2001, Cancer.

Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.

P. Mclaughlin, J. Cox, F. Cabanillas, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings.

J. Cox, C. Koller, C. Ha, 1999, Leukemia & lymphoma.

N2 (clinical) non-small cell carcinoma of the lung (NSCCL): Prospective trials of radiation therapy with total doses ≥ 60 GY by the radiation therapy oncology group (RTOG)

K. Shin, C. Perez, J. Cox, 1989 .

Dose-response in small cell carcinoma.

J. Cox, J. Cox, 1988, International journal of radiation oncology, biology, physics.

Moss' radiation oncology : rationale, technique, results

J. Cox, W. Moss, 1994 .

Interfraction interval is major determinant of late effects, but not acute effects or tumor control, with hyperfractionated irradiation (HFX) of carcinomas of upper respiratory and digestive tracts (URDT)

P. Rubin, T. Pajak, K. Fu, 1990 .

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017, JAMA oncology.

Poster PresentationThe 5-Year Outcome for Patients Diagnosed With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemotherapy and Proton Beam Therapy: Locally Advanced Non-Small Cell Lung Cancer

D. Gomez, R. Komaki, Z. Liao, 2014 .

Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

What is the lowest effective biologic dose for prophylactic cranial irradiation?

J. Cox, R. Komaki, R. Byhardt, 1985, American journal of clinical oncology.

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

IMRT Versus Passively Scattered Proton Therapy (PSPT) for Locally Advanced NSCLC -- Impact of Changing Techniques and Technologies Over the Course of a Randomized Trial

R. Mohan, R. Komaki, Z. Liao, 2012 .

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

Joe Y. Chang, W. Liu, R. Mohan, 2014, Radiation oncology.

Intensity-Modulated Proton Therapy Reduces Normal Tissue Doses Compared with Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Radiotherapy for Extensive Stage IIIB Non-Small Cell Lung Cancer: A Virtual Clinical Study

Joe Y. Chang, Xiaodong Zhang, J. Cox, 2010 .

Comparison of Conformity Index In 3D-CRT, IMRT, and Proton Therapy in Lung Cancer: In Reply to Dr. Armstrong

Joe Y. Chang, Xiaodong Zhang, J. Cox, 2007 .

Significantly Reduced Normal Tissue Dose with Proton Radiotherapy Compared with 3D-CRT or IMRT in Stage I or Stage III Non-Small Cell Lung Cancer

R. Mohan, R. Komaki, Z. Liao, 2005 .

Twice‐daily Thoracic Radiotherapy for Limited‐stage Small‐cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis

J. Welsh, Steven H. Lin, R. Komaki, 2018, Clinical lung cancer.

PD5-1-8: 4D CT imaging impacts lung volume definitions and dose-volume relationships in radiation treatment of non-small cell lung cancer

Joe Y. Chang, Lei Dong, R. Mohan, 2007 .

FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy

Joe Y. Chang, R. Komaki, J. Erasmus, 2012, Radiation Oncology.

Time dose relationships in adenocarcinoma. The importance of the interval to surgery following external pelvic irradiation

J. Cox, J. Wilson, J. A. D. Regato, 1978 .

Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Lei Dong, R. Mohan, J. Purdy, 2011, International journal of radiation oncology, biology, physics.

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Lei Dong, R. Mohan, D. Kuban, 2010, International journal of radiation oncology, biology, physics.

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.

R. Herbst, C. Stevens, R. Komaki, 2004, International journal of radiation oncology, biology, physics.

Prognostic factors in malignant lymphoreticular tumors of the small bowel and ileocecal region: a review of 50 case histories.

J. Cox, 1979, International journal of radiation oncology, biology, physics.

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.

P. Rubin, T. Pajak, J. Cooper, 1989, International journal of radiation oncology, biology, physics.

Time dose relationships in endometrial adenocarcinoma: importance of the interval from external pelvic irradiation to surgery.

J. Cox, J. Wilson, J. A. del Regato, 1980, International journal of radiation oncology, biology, physics.

Initial evaluation of reduced fractionation in the irradiation of malignant epithelial tumors.

J. Cox, M. Greenberg, D. Eisert, 1976, AJR. American journal of roentgenology.

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.

Radhe Mohan, Joe Y. Chang, Xiaoning Pan, 2010, International journal of radiation oncology, biology, physics.

Radiation therapy in the treatment of malignant fibrous histiocytoma.

J. Cox, L. Clowry, N. Rangala, 1981, International journal of radiation oncology, biology, physics.

Ackerman and del Regato's cancer: Diagnosis, treatment, and prognosis

James D. Cox, L. Ackerman, J. Cox, 1977 .

Complications of radiation therapy and factors in their prevention

J. Cox, R. Komaki, R. Byhardt, 1986, World Journal of Surgery.

Outcomes Using Doxorubicin-Based Chemotherapy with or without Radiotherapy for Early-Stage Peripheral T-cell Lymphomas

F. Cabanillas, J. Cox, R. Wilder, 2002, Leukemia & lymphoma.

Radioprotectors and Chemoprotectors in the Management of Lung Cancer

R. Komaki, Z. Liao, J. Cox, 2011 .

Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group.

J. Cox, R. Yesner, J. Cox, 1979, The American review of respiratory disease.

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Thomas Guerrero, Radhe Mohan, Joe Y. Chang, 2004, International journal of radiation oncology, biology, physics.

Failure analysis in diagnostic and treatment strategies in cancer management

J. Cox, 1983 .

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Zhongxing Liao, Xiong Wei, Helen H Liu, 2005, International journal of radiation oncology, biology, physics.

Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.

Radhe Mohan, Lei Dong, Zhongxing Liao, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?

E. Holliday, R. Komaki, J. Cox, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Radhe Mohan, Stephen M Hahn, John V Heymach, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Benjamin Movsas, Walter J Curran, Elizabeth Gore, 2011, Journal of the National Cancer Institute.

Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.

A S Garden, C A Meyers, A. Garden, 1995, International journal of radiation oncology, biology, physics.

Consensus statement: Guidelines for PSA following radiation therapy

James D. Cox, David J. Grignon, James T. Parsons, 1997 .

Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Helen H Liu, J. Ajani, S. Swisher, 2006, International journal of radiation oncology, biology, physics.

Thymoma. A retrospective study of 87 cases

J. Cox, A. Pollack, J. Putnam, 1994, Cancer.

Prevention of Diagnostic and Treatment-Related Sequelae in Stage I and II Hodgkin´s Disease

J. Cox, C. Ha, J. Cox, 1999 .

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Z. Liao, S. Tucker, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.

L. Fuller, J. Cox, B. Brown, 1997, International journal of radiation oncology, biology, physics.

Hodgkin's disease stage I and II. A comparison between two different treatment policies

J. Cox, T. J. Stoffel, 1977, Cancer.

Long-term results with radiotherapy for Stage I-II follicular lymphomas.

S. Tucker, L. Fuller, P. Mclaughlin, 2001, International journal of radiation oncology, biology, physics.

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

R. Mohan, M. Martel, R. Komaki, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.

P. Mclaughlin, F. Cabanillas, J. Cox, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary C utaneous N on-Hodgkin's L ymphoma o f A nn A rbor Stage I : P referential C utaneous R elapses b ut H igh C ure Rate W ith D oxorubicin-Base d T herapy

P. Mclaughlin, J. Cox, F. Cabanillas, 2001 .

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

J. Cox, F. Cabanillas, B. Andersson, 2004, Bone Marrow Transplantation.

Design and Implementation of Clinical Trials of Ion Beam Therapy

J. Cox, J. Cox, 2012 .

Should randomized clinical trials be required for proton radiotherapy?

J. Cox, James D Cox, M. Goitein, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).

S. Tucker, P. Mclaughlin, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Radiochemotherapy of esophageal cancer.

Z. Liao, J. Cox, R. Komaki, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

J. Ajani, J. Roth, S. Swisher, 2004, International journal of radiation oncology, biology, physics.

Carcinoma of the pancreas: results of irradiation for unresectable lesions.

J. Cox, R. Kline, R. Komaki, 1980, International journal of radiation oncology, biology, physics.

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

Terry L. Smith, L. Fuller, P. Mclaughlin, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

P. Mclaughlin, J. Cox, F. Cabanillas, 1998, Blood.

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

Joe Y. Chang, A. Garg, T. Guerrero, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Daniel Gomez, Lei Dong, Zhongxing Liao, 2011, International journal of radiation oncology, biology, physics.

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma

F. Cabanillas, J. Cox, R. Wilder, 2001, Cancer.

Irradiation of bronchial carcinoma--II. Pattern of spread and potential for prophylactic irradiation.

J. Cox, R. Komaki, D. Eisert, 1977, International journal of radiation oncology, biology, physics.

Carcinomas of the oropharynx treated with hyperfractionated radiation therapy on Radiation Therapy Oncology Group Protocol 8313.

S. McDonald, T. Pajak, K. Fu, 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06.

H. Sandler, R. Valicenti, J. Michalski, 2011, International journal of radiation oncology, biology, physics.

Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.

P. Okunieff, R. Abrams, W. Shipley, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

S. Tucker, J. Cox, F. Cabanillas, 2003, International journal of radiation oncology, biology, physics.

Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer.

C. Stevens, R. Komaki, Z. Liao, 2002, International journal of radiation oncology, biology, physics.

The role of local radiation therapy for mediastinal disease in adults with T‐cell lymphoblastic lymphoma

H. Kantarjian, J. Cortes, J. Cox, 2002, Cancer.

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone

J. Cox, R. Wilder, D. Weber, 2002, Cancer.

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.

C. Pelloski, J. Cox, F. Cabanillas, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.

S. Tucker, J. Cox, F. Cabanillas, 2000, International journal of radiation oncology, biology, physics.

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

R. Komaki, L. Gaspar, K. Fu, 1999 .

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.

R. Komaki, J. Cox, F. Fossella, 1998, International journal of radiation oncology, biology, physics.

Localized primary malignant lymphoma of bone.

J. Murray, L. Fuller, J. Cox, 1997, International journal of radiation oncology, biology, physics.

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.

D. Grignon, R. Abrams, F. Sarkar, 1997, Journal of the National Cancer Institute.

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials.

T. Pajak, B. Emami, J. Cox, 1993, International journal of radiation oncology, biology, physics.

Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non‐small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83‐11

W. Curran, K. Shin, T. Phillips, 1991, Cancer.

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group.

K. Shin, C. Perez, B. Emami, 1991, International journal of radiation oncology, biology, physics.

Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.

P. Rubin, W. Sause, J. Cox, 1988, International journal of radiation oncology, biology, physics.

Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients.

Z. Petrovich, J. Cox, R. Middleton, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a radiation therapy oncology group (RTOG) protocol

K. Shin, T. Pajak, B. Emami, 1993 .

Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation.

R. Komaki, S. Tucker, J. Cox, 1998, International journal of radiation oncology, biology, physics.

Cardiac localization of 99mTc-(Sn)-pyrophosphate following irradiation of the chest.

J. Cox, H. Swartz, J. Soin, 1977, Radiology.

Incidence of Second Malignancy after Successful Treatment of Limited‐Stage Small–Cell Lung Cancer and Its Effects on Survival

J. Welsh, Steven H. Lin, R. Komaki, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Metformin use and improved response to therapy in esophageal adenocarcinoma

T. Guerrero, J. Ajani, J. Welsh, 2013, Acta oncologica.

Combined methotrexate and high‐dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma

J. Cox, R. Byhardt, T. Anderson, 1985, Cancer.

Molecular Basis of Radiation Therapy

W. Woodward, J. Cox, J. Cox, 2008 .

Influence of preoperative irradiation on failures of endometrial carcinoma with high risk of lymph node metastasis

J. Cox, R. Komaki, A. Hartz, 1984, American journal of clinical oncology.

Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma.

J. Cox, P. Allen, Jing Li, 2011, International journal of radiation oncology, biology, physics.

Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer.

I. Rosen, G. Starkschall, T. Fischer, 2001, Radiology.

Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma

J. Cox, A. Hartz, R. Mattingly, 1984, Cancer.

Non-small cell lung cancer. Role of radiation therapy.

J. Cox, J. Cox, 1986, Chest.

Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?

Joe Y. Chang, S. McGovern, M. McAleer, 2009, Cancer.

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer

Steven H. Lin, R. Komaki, A. Amini, 2012, Radiation oncology.

Large‐dose fractionation. (Hypofractionation)

J. Cox, J. Cox, 1985, Cancer.

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interfractional reproducibility of lung tumor location using various methods of respiratory motion mitigation.

R. Mohan, G. Starkschall, P. Balter, 2011, International journal of radiation oncology, biology, physics.

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Joe Y. Chang, J. Ajani, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.

P. Thall, M. Mehta, M. Suntharalingam, 2017, Radiotherapy and Oncology.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Are the results of RTOG 0617 mysterious?

J. Cox, 2012, International journal of radiation oncology, biology, physics.

Clinical research on the treatment of locally advanced lung cancer. Final report of VALG protocol 13 limited

Z. Petrovich, J. Cox, M. Ohanian, 1978, Cancer.

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis

Steven H. Lin, R. Komaki, J. Cox, 2018, Radiation Oncology.

The prognostic significance of flow cytometric DNA analysis

A. Sahin, J. Cox, A. Pollack, 1992, Cancer.

Toward consistent local control of certain malignant tumors. Endoradiotherapy with iridium 192.

J. Cox, D. Chassagne, B. Pierquin, 1971, Radiology.

Interaction of thoracic irradiation and chemotherapy on local control and survival in small cell carcinoma of the lung.

J. Cox, R. Byhardt, J. Wilson, 1979, Cancer treatment reports.

Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1983, American journal of clinical oncology.

Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy

L. Fuller, J. Cox, F. Cabanillas, 1995, Cancer.

Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.

R. Mohan, J. Ajani, J. Roth, 2003, International journal of radiation oncology, biology, physics.

Malignant lymphoma of the uterine cervix

J. Cox, M. Greenberg, W. Gunn, 1984, Cancer.

Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: correlation with survival.

J. Cox, R. Komaki, R. Stark, 1983, International journal of radiation oncology, biology, physics.

Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung

Z. Petrovich, J. Cox, W. Mietlowski, 1979, Cancer.

Advanced carcinoma of the nasopharynx

Z. Petrovich, J. Cox, R. Byhardt, 1982 .

Advanced carcinoma of the nasopharynx. A clinical study of 274 patients.

Z. Petrovich, J. Cox, R. Byhardt, 1982, Radiology.

Hyperfractionation in the radiation therapy of unresectable non-oat cell carcinoma of the lung: preliminary report of a RTOG Pilot Study.

J. Cox, M. Diener-West, H. Seydel, 1985, International journal of radiation oncology, biology, physics.

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

S. Tucker, J. Cox, F. Cabanillas, 2001, International journal of radiation oncology, biology, physics.

Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials--results of the Radiation Therapy Oncology Group (RTOG) analysis.

W. Curran, S. Leibel, J. Cox, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma

S. Tucker, F. Cabanillas, J. Cox, 2002, Cancer.

Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.

S. Tucker, J. Cox, F. Cabanillas, 1999, International journal of radiation oncology, biology, physics.

Clinical report on the treatment of locally advanced lung cancer

Z. Petrovich, J. Cox, W. Mietlowski, 1977 .

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease

J. Cox, F. Cabanillas, A. Younes, 2002, Cancer.

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity

S. Tucker, J. Cox, B. Andersson, 2001, Cancer.

Radiotherapy Alone for Lymphocyte‐Predominant Hodgkin's Disease

J. Cox, F. Cabanillas, A. Younes, 2002, Cancer journal.

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer

Joe Y. Chang, M. Spitz, J. Minna, 2010, PloS one.

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy

Q. Wei, R. Komaki, Z. Liao, 2013, PloS one.

The significance of needle biopsy after irradiation for stage c adenocarcinoma of the prostate

J. Cox, T. J. Stoffel, 1977 .

Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy.

Radhe Mohan, Ehud Mendel, Laurence D Rhines, 2003, International journal of radiation oncology, biology, physics.

Changes in Pulmonary Function after Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, or Proton Beam Therapy for Non-Small Cell Lung Cancer

R. Mohan, D. Gomez, Z. Liao, 2014 .

Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.

R. Mohan, D. Gomez, R. Komaki, 2012, International journal of radiation oncology, biology, physics.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Radhe Mohan, Joe Y. Chang, Yixiu Kang, 2006, International journal of radiation oncology, biology, physics.

A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls

T. Buchholz, A. Sigurdson, J. Cox, 2004, Cancer.

Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.

Jinzhong Yang, J. Welsh, R. Komaki, 2011, International journal of radiation oncology, biology, physics.

Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.

W. Hong, J. Roth, T. McDonnell, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Passing the baton--in a marathon.

J. Cox, 2011, International journal of radiation oncology, biology, physics.

Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma

L. Fuller, P. Mclaughlin, J. Cox, 1995, Cancer.

Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiotherapy.

Laurence Court, Lei Dong, Yongbin Zhang, 2013, Practical radiation oncology.

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Joe Y. Chang, Zhongxing Liao, James D. Cox, 2011, Front. Oncol..

Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.

J. Cox, R. Wilder, C. Ha, 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Cure and follicular lymphoma.

J. Cox, J. Cox, 1997, International journal of radiation oncology, biology, physics.

Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior.

J. Cox, P. Perkins, J. Putnam, 1997, American journal of clinical oncology.

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

S. Tucker, J. Cox, F. Cabanillas, 2002, Cancer.

Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.

R. Mohan, R. Komaki, Z. Liao, 2008, International journal of radiation oncology, biology, physics.

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.

J. Jacobs, T. Pajak, J. Cooper, 1996, International journal of radiation oncology, biology, physics.

Locally advanced adenocarcinoma of the endometrium: Results of irradiation with and without subsequent hysterectomy

J. Cox, J. Wilson, M. Greenberg, 1978, Cancer.

Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.

Thomas Guerrero, Radhe Mohan, T. Guerrero, 2005, International journal of radiation oncology, biology, physics.

Radiation Oncology; Rationale, Technique, Results, 9th edition

James D. Cox, K. Kian Ang, J. Cox, 2010 .

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

A. Markoe, H. Sandler, K. Bae, 2010, International journal of radiation oncology, biology, physics.

Superior sulcus tumors: Results of irradiation of 36 patients

J. Cox, R. Komaki, James Roh, 1981, Cancer.

Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.

Jeff M Michalski, Mack Roach, James A Purdy, 2005, International journal of radiation oncology, biology, physics.

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

Richard K Valicenti, Jeff M Michalski, Mack Roach, 2004, International journal of radiation oncology, biology, physics.

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

P. Rubin, S. Doggett, W. Sause, 1991, International journal of radiation oncology, biology, physics.

Definition and Management of Superior Sulcus Tumors

J. Erasmus, J. Cox, R. Mehran, 2018, Archives of Oncology and Cancer Therapy.

THE MANAGEMENT OF SUPERIOR SULCUS TUMORS

W. Hong, J. Roth, C. Stevens, 2001 .

The management of superior sulcus tumors.

R. Komaki, J. Cox, J. Putnam, 2000, Seminars in surgical oncology.

Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation.

A. Garden, J. Cox, C. Mountain, 1990, International journal of radiation oncology, biology, physics.

The radiation therapy oncology group: An update of clinical research activities

T. Pajak, T. Phillips, S. Leibel, 1991 .

interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313

P. Rubin, T. Pajak, K. Fu, 1992, Cancer.

Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.

Joe Y. Chang, T. Guerrero, J. Ajani, 2005, International journal of radiation oncology, biology, physics.

Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.

J. Roth, R. Komaki, J. Cox, 2000, International journal of radiation oncology, biology, physics.

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

P. Schellhammer, R. Kaplan, E. Hammond, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brain metastasis in patients with superior sulcus tumors

J. Cox, A. Hartz, R. Byhardt, 1987, Cancer.

Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.

P. Thall, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.

P. Rubin, T. Pajak, K. Fu, 1990, International journal of radiation oncology, biology, physics.

Clinical Perspectives of Recent Developments in Fractionation

J. Cox, 1992 .

RTOG ALTERED FRACTIONATION TRIALS

D. Nelson, T. Pajak, K. Fu, 1992 .

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.

W. Curran, W. Sause, B. Emami, 1997, International journal of radiation oncology, biology, physics.

Heterogeneous planning for homogeneous protocols.

K. Forster, G. Starkschall, C. Stevens, 2004, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Clinical implications of incorporating heterogeneity corrections in mantle field irradiation.

R. Kudchadker, J. Cox, K. Prado, 2003, International journal of radiation oncology, biology, physics.

Factors Associated With Severe Pneumonitis for Limited Stage Small Cell Lung Cancer

R. Mohan, E. Holliday, Steven H. Lin, 2015 .

Comparing Risk Of Radiation Pneumonitis After Intensity-modulated Radiotherapy Vs. Proton Therapy

R. Mohan, Z. Liao, S. Tucker, 2014 .

Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Radhe Mohan, Zhongxing Liao, Sue S Yom, 2007, International journal of radiation oncology, biology, physics.

Aortic dose constraints when reirradiating thoracic tumors.

M. Martel, D. Gomez, J. Welsh, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation dose escalation in non-small cell carcinoma of the lung.

R. Arriagada, R. Komaki, J. Cox, 2004, Seminars in radiation oncology.

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

R. Komaki, B. Emami, J. Cox, 1997, American journal of clinical oncology.

A Radiation Therapy Oncology Group experience: chemotherapy/radiation therapy of lung cancer

T. Pajak, W. Sause, C. Perez, 1993 .

Is adenocarcinoma/large cell carcinoma the most radiocurable type of cancer of the lung?

J. Cox, R. Komaki, A. Hartz, 1986, International journal of radiation oncology, biology, physics.

Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of randomized trial

Z. Petrovich, J. Cox, K. Stanley, 1981, Cancer.

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.

P. Rubin, T. Pajak, K. Fu, 1991, International journal of radiation oncology, biology, physics.

Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung. Preliminary report of a cooperative trial

Z. Petrovich, J. Cox, K. Stanley, 1977, Cancer.

Cranial irradiation in cancer of the lung of all cell types.

Z. Petrovich, J. Cox, R. Yesner, 1981, JAMA.

Induction or Concurrent Chemotherapy and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

R. Komaki, J. Cox, J. Cox, 1999 .

The role of thoracic and cranial irradiation for small cell carcinoma of the lung.

J. Cox, R. Komaki, R. Byhardt, 1981, International journal of radiation oncology, biology, physics.

Internal mammary lymphoscintigraphy in patients with breast cancer. Correlation with computed tomography and impact on radiation therapy planning.

J. Cox, R. Komaki, J. Wilson, 1983, Radiology.

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

W. Sause, J. Cox, R. Komaki, 2000, International journal of radiation oncology, biology, physics.

Importance of end points in determining effectiveness of thoracic irradiation for small cell lung carcinoma

J. Cox, 1985 .

Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer

J. Cox, D. Stewart, 2010 .

Status of particle therapy for lung cancer

Steven H. Lin, Z. Liao, J. Cox, 2011, Acta oncologica.

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer

Joe Y. Chang, R. Komaki, Z. Liao, 2011, Cancer.

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.

W. Hong, R. Herbst, R. Komaki, 2009, International journal of radiation oncology, biology, physics.

Phase 2 study of high‐dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer

Joe Y. Chang, R. Mohan, R. Komaki, 2011, Cancer.

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

Radhe Mohan, Lei Dong, Renaud de Crevoisier, 2005, International journal of radiation oncology, biology, physics.

Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy.

Q. Wei, D. Gomez, Z. Liao, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005, Clinical Cancer Research.

Primary non-Hodgkin lymphoma of the large bowel.

L. Fuller, J. Cox, P. Allen, 1997, Radiology.

Guidelines and Techniques for Image-Guided Radiotherapy for Non–Small Cell Lung Cancer

Joe Y. Chang, R. Komaki, J. Cox, 2007 .

Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer.

R. Mohan, Steven H. Lin, G. Starkschall, 2012, International journal of radiation oncology, biology, physics.

PET/CT Fusion with Treatment Planning CT (TP CT) Shows Predominant Pattern of Locoregional Failure in Esophageal Patients Treated with Chemoradiation (CRT) is in GTV

T. Guerrero, M. McAleer, M. Bucci, 2008 .

Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

A. Markoe, H. Sandler, J. Purdy, 2004, International journal of radiation oncology, biology, physics.

The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer.

J. Cox, R. Kline, 1983, Seminars in urology.

109 RTOG 8808 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable now small cell lung cancer with minimum three year follow-up

W. Curran, R. Komaki, R. Livingston, 1995 .

Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

R. Mohan, R. Komaki, Z. Liao, 2006, International journal of radiation oncology, biology, physics.

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Radhe Mohan, Lei Dong, Zhongxing Liao, 2004, International journal of radiation oncology, biology, physics.

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

A. Markoe, H. Sandler, J. Purdy, 2003, International journal of radiation oncology, biology, physics.

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.

A. Markoe, H. Sandler, J. Purdy, 2002, Seminars in radiation oncology.

The M. D. Anderson proton therapy system.

Radhe Mohan, Kazuo Hiramoto, Martin Bues, 2009, Medical physics.

Clinical science and patient care: lessons from cooperative randomized clinical trials.

J. Cox, 1997, International journal of radiation oncology, biology, physics.

APhase IClinicalTrial ofThoracic Radiotherapy and Concurrent Celecoxib for Patientswith Unfavorable Performance Status Inoperable/Unresectable Non^Small Cell Lung Cancer

Joe Y. Chang, Z. Liao, J. Cox, 2005 .

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.

R. Mohan, J. Purdy, W. Bosch, 2012, International journal of radiation oncology, biology, physics.

Improving radiation conformality in the treatment of non-small cell lung cancer.

Joe Y. Chang, J. Cox, J. Cox, 2010, Seminars in radiation oncology.

Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.

Joe Y. Chang, R. Mohan, Helen H Liu, 2009, International journal of radiation oncology, biology, physics.

Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases.

E. Mendel, L. Rhines, A. Shiu, 2004, International journal of radiation oncology, biology, physics.

Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.

He Wang, J. O'Daniel, R. Mohan, 2006, International journal of radiation oncology, biology, physics.

Randomized dose-searching phase ILE/II trials of fractionation in radiation therapy for cancer.

T. Pajak, J. Cox, M. Diener-West, 1991, Journal of the National Cancer Institute.

Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.

Srinivasan Vijayakumar, J. Cox, M. Bondy, 1998, International journal of radiation oncology, biology, physics.

Whole-limb irradiation of the lower calf using a six-field electron technique.

J. Cox, K. Hogstrom, R. Gastorf, 1996, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.

Joe Y. Chang, R. Mohan, S. Swisher, 2011, International journal of radiation oncology, biology, physics.

The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience.

P. Rubin, W. Sause, C. Perez, 1991, International journal of radiation oncology, biology, physics.

1127: Socio-Demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-Analysis

B. Movsas, J. Cox, G. Hanks, 2006 .

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

Joe Y. Chang, D. Gomez, R. Komaki, 2014, International journal of radiation oncology, biology, physics.

Prognostic Significance of Total Lymphocyte Count, Neutrophil‐to‐lymphocyte Ratio, and Platelet‐to‐lymphocyte Ratio in Limited‐stage Small‐cell Lung Cancer

Steven H. Lin, R. Komaki, J. Cox, 2019, Clinical lung cancer.

Comparison of surface doses from spot scanning and passively scattered proton therapy beams

J. Cox, M. Gillin, Andrew L Lee, 2009, Physics in medicine and biology.

Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.

Radhe Mohan, Joe Y. Chang, Daniel Gomez, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Novel approaches to locally advanced unresectable non-small cell lung cancer.

C. Stevens, R. Komaki, J. Cox, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cutaneous lymphoid hyperplasia: results of radiation therapy.

J. Cox, J. Wilson, L. Olson, 1985, Radiology.

Proton beam therapy and concurrent chemotherapy for esophageal cancer.

R. Mohan, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.

Radhe Mohan, Zhongxing Liao, Wayne D Newhauser, 2008, International journal of radiation oncology, biology, physics.

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.

J. Purdy, M. Roach, W. Bosch, 2004, International journal of radiation oncology, biology, physics.

Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

R. Mohan, D. Gomez, R. Komaki, 2012, International journal of radiation oncology, biology, physics.

Therapeutic ratio and fractionation in cancer of the lung.

J. Cox, M. Bauer, 1988, Frontiers of radiation therapy and oncology.

Brachytherapy in Lung Cancer

J. Cox, B. Hilaris, J. Cox, 1986 .

Brachytherapyin Lung Cancer

J. Cox, B. Hilaris, J. Cox, 2017 .

Acute radiation effects on cutaneous microvasculature: evaluation with a laser Doppler perfusion monitor.

H. Amols, J. Cox, R. Komaki, 1988, Radiology.

The risk of developing a second cancer after receiving craniospinal proton irradiation

R. Mohan, J. Cox, M. Stovall, 2009, Physics in medicine and biology.

In response to bentzen and thames: Regarding dose-response relationships for late radiation effects in the head and neck: Analysis of RTOG 8313 trial, fu et al. IJROBP 32:577–588; 1995

T. Pajak, K. Fu, J. Cox, 1996 .

Late effects of hyperfractionated-radiotherapy for head and neck cancer--in response to Drs. Withers and Taylor, IJROBP 32:887-888; 1995.

K. Fu, J. Cox, 1995, International Journal of Radiation Oncology, Biology, Physics.

SU‐FF‐J‐104: Impact of Anatomical Changes On Dose Distributions During Three‐Dimensional Radiotherapy (3D‐CRT) of Lung Cancer: Preliminary Study Using Multiple 4‐DCT

Joe Y. Chang, R. Mohan, G. Starkschall, 2007 .

RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?

H. Sandler, J. Purdy, R. Valicenti, 2003, International journal of radiation oncology, biology, physics.

Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

R. Mohan, R. Komaki, Z. Liao, 2006, International journal of radiation oncology, biology, physics.

Reduced Incidence of Severe Acute Toxicities in Esophageal Cancer Treated with Proton Therapy

D. Gomez, Steven H. Lin, R. Komaki, 2015 .

Outcomes with Esophageal Cancer Radiation Therapy

Joe Y. Chang, J. Ajani, S. Swisher, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Computed tomography in the staging of small cell lung cancer: implications for combined modality therapy.

J. Cox, W. Foley, G. Unger, 1985, International Journal of Radiation Oncology, Biology, Physics.

Age dramatically impacts on the quality-adjusted time without symptoms or toxicity (Q-Twist) in locally advanced non-Small cell lung cancer (LA-NSCLC)-a radiation therapy oncology group (RTOG) analysis

R. Komaki, W. Sause, B. Movsas, 2000 .

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities

I. Hsu, E. Horwitz, D. D'Souza, 2018, Advances in radiation oncology.

Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.

Joe Y. Chang, R. Mohan, D. Gomez, 2016, Journal of pain and symptom management.

Radiation therapy of cancer of the prostate.

J. Cox, J. Wilson, 1975, Wisconsin medical journal.

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis

J. Welsh, Steven H. Lin, R. Komaki, 2018, Radiation oncology.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Joe Y. Chang, T. Guerrero, J. Ajani, 2004, International journal of radiation oncology, biology, physics.

111: V20 Predicts Fatal Pulmonary Toxicity After Extrapleural Pneumonectomy and Intensity Modulated Radiation Therapy

T. Guerrero, K. Forster, C. Stevens, 2006 .

2472 : The Volume of Lung Receiving low Radiation Doses Is Associated With Treatment Related Lung Toxicity When Irradiating Tumors in the Thorax

R. Mohan, Hanli Liu, R. Komaki, 2006 .

Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.

F. Cabanillas, J. Cox, P. Allen, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Non-small Cell Lung Cancer* Role of RadiationTherapy

J. Cox, J. Cox, 2017 .

Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.

Radhe Mohan, Lei Dong, Wayne D Newhauser, 2007, International journal of radiation oncology, biology, physics.

Intensity Modulated Proton Therapy for Head-and-Neck Cancer: The First Clinical Experience

R. Mohan, A. Garden, K. Ang, 2012 .

Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.

R. Mohan, J. Purdy, W. Bosch, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate.

J. Cox, T. J. Stoffel, 1977, Cancer.

Radiation Therapy Oncology Group (RTOG) Altered Fractionation Trials

K. Ang, K. Fu, J. Cox, 1995 .

Should Randomized Clinical Trials Be Required for

J. Cox, M. Goitein, 2008 .

Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.

George Starkschall, Radhe Mohan, Joe Y. Chang, 2008, International journal of radiation oncology, biology, physics.

Radiotherapy and Hodgkin's lymphoma.

J. Cox, P. Das, C. Ha, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.

Heng Li, Li Liao, Joe Y. Chang, 2014, Practical radiation oncology.

On the interplay effects with proton scanning beams in stage III lung cancer.

Heng Li, Li Liao, Joe Y. Chang, 2014, Medical physics.

Immediately Concurrent Chemoradiation Therapy Is Associated With Improved 2-Year Overall Survival in Patients With Limited Small-Cell Lung Cancer

J. Welsh, Steven H. Lin, R. Komaki, 2016 .

Completing Thoracic Radiation Therapy With Concurrent Chemotherapy Within 6 weeks Is Important for Reducing Distant Disease in Patients With Limited-Stage Small Cell Lung Cancer

J. Welsh, Steven H. Lin, R. Komaki, 2016 .

Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.

Z. Liao, P. Mclaughlin, J. Manning, 2000, International journal of radiation oncology, biology, physics.

Malt (mucosa associated lymphoid tissue) lymphoma with supradiaphragmatic presentation: Natural history and patterns of failure

Z. Liao, P. Mclaughlin, J. Manning, 1998 .

Limited-stage small-cell lung cancer: patient survival after combined chemotherapy and radiation therapy with and without treatment protocols.

J. Cox, P. Perkins, P. Allen, 1995, Radiology.

Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.

L. North, J. Cox, F. Cabanillas, 1998, International journal of radiation oncology, biology, physics.

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study

S. Swisher, Steven H. Lin, R. Komaki, 2017, Advances in radiation oncology.

The Institute of Medicine, the National Cancer Institute, and clinical trials.

J. Cox, 2011, International journal of radiation oncology, biology, physics.

IMRT reduces lung irradiation in distal esophageal cancer over 3D CRT

T. Guerrero, R. Mohan, C. Stevens, 2003 .

Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.

Radhe Mohan, Daniel Gomez, James D. Cox, 2016 .

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

R. Mohan, M. Martel, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

Irradiation of stage I and II Hodgkin's disease.

J. Cox, J. Fazekas, W. Turner, 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.

Chapter 1 – Physical and Biologic Basis of Radiation Therapy

J. Cox, E. Hall, 2010 .

2090 Radiation therapy oncology group: 3-D CRT quality assurance guidelines

L. Verhey, T. Phillips, J. Purdy, 1995 .

Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients

T. Pajak, B. Emami, J. Cox, 1992 .

Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy

G. Gladish, D. Gomez, R. Komaki, 2014, American journal of clinical oncology.

Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.

E. Shaw, N. Bleehen, J. Cox, 1994, Lung cancer.

Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.

S. Tucker, L. Fuller, J. Cox, 1998, Radiology.

The significance of needle biopsy after irradiation for stage c adenocarcinoma of the prostate

J. Cox, T. J. Stoffel, 1977, Cancer.

Radiation oncology: postgraduate medical education in the United States, 1988.

J. Cox, L. Brady, D. Flynn, 1989, International Journal of Radiation Oncology, Biology, Physics.

Training in therapeutic radiology in the United States, 1984.

J. Cox, D. D. Pittman, J. del Regato, 1985, International journal of radiation oncology, biology, physics.

Carcinoma of the pancreas: Results of the conventional irradiation for unresectable lesions

J. Cox, R. Komaki, J. Wilson, 1978 .

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Time, dose, and fractionation in radiation therapy: an historical perspective.

J. Cox, 1988, Frontiers of radiation therapy and oncology.

New frontiers in the treatment of lung cancer.

D. Ettinger, E. Zinreich, J. Cox, 1985, Critical reviews in oncology/hematology.

Failure Patterns and Toxicity of Concurrent Proton Therapy and Chemotherapy for Stage III Non–small Cell Lung Cancer

R. Mohan, M. Bucci, R. Komaki, 2009 .

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

W. Curran, R. Livingston, W. Sause, 1995, Journal of the National Cancer Institute.

Total pulmonary irradiation for metastases from testicular carcinoma.

J. Cox, J. Maier, N. Ream, 1972, Radiology.

The prognostic significance of histologic subtyping in small cell carcinoma of the lung

J. Cox, R. Byhardt, U. Almagro, 1984, American journal of clinical oncology.

Local control of squamous carcinoma of oral cavity and oropharynx with 3 vs 5 treatment fractions per week.

J. Cox, R. Byhardt, M. Greenberg, 1977, International journal of radiation oncology, biology, physics.

Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.

J. Cox, R. Komaki, R. Byhardt, 1980, International Journal of Radiation Oncology, Biology, Physics.

Alterations of fractionation.

J. Cox, 1984, International journal of radiation oncology, biology, physics.

Veterans administration lung cancer study group

Z. Petrovich, J. Cox, W. Mietlowski, 1977 .

Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.

Radhe Mohan, Joe Y. Chang, Eugene J Koay, 2012, International journal of radiation oncology, biology, physics.

Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.

L. North, J. Cox, F. Cabanillas, 1998, International journal of radiation oncology, biology, physics.

PD4-1-6: Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher doses

Joe Y. Chang, M. McAleer, M. Bucci, 2007 .

Differences in Breast Cancer Treatment and Survival Between Older and Younger Women

S. Singletary, J. Cox, P. Perkins, 1999, The breast journal.

1011 : A Review of the Activities of the ITC in Support of RTOG Advanced Technology Clinical Trials

W. Curran, J. Purdy, W. Bosch, 2006 .

Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.

Joe Y. Chang, S. Shirvani, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

In response to Bentzen et al., IJROBP 32:1531-1534; 1995.

T. Pajak, J. Cox, R. Caplan, 1995, International journal of radiation oncology, biology, physics.

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

W. Sause, B. Movsas, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy.

J. Purdy, J. Michalski, J. Cox, 1996, Frontiers of radiation therapy and oncology.

Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.

R. Mohan, M. Martel, R. Komaki, 2010, International journal of radiation oncology, biology, physics.